Overview

A Study of Carbamazepine (CBZ) and MK-8527 in Healthy Adult Participants (MK-8527-012)

Status:
COMPLETED
Trial end date:
2025-07-17
Target enrollment:
Participant gender:
Summary
The goal of this study is to learn what happens to MK-8527 in a healthy person's body over time when MK-8527 is given alone and with the medication CBZ.
Phase:
PHASE1
Details
Lead Sponsor:
Merck Sharp & Dohme LLC